Literature DB >> 8107237

Repression of enhancer II activity by a negative regulatory element in the hepatitis B virus genome.

W Y Lo1, L P Ting.   

Abstract

Enhancer II of human hepatitis B virus has dual functions in vivo. Located at nucleotides (nt) 1646 to 1741, it can stimulate the surface and X promoters from a downstream position. Moreover, the same sequence can also function as upstream regulatory element that activates the core promoter in a position- and orientation-dependent manner. In this study, we report the identification and characterization of a negative regulatory element (NRE) upstream of enhancer II (nt 1613 to 1636) which can repress both the enhancer and upstream stimulatory function of the enhancer II sequence in differentiated liver cells. This NRE has marginal inhibitory effect by itself but a strong repressive function in the presence of a functional enhancer II. Mutational analysis reveals that sequence from nt 1616 to 1621 is required for repression of enhancer activity by the NRE. Gel shift analysis reveals that this negative regulatory region can be recognized by a specific protein factor(s) present at the 0.4 M NaCl fraction of HepG2 nuclear extracts. The discovery of the NRE indicates that HBV gene transcription is controlled by combined effects of both positive and negative regulation. It also provides a unique system with which to study the mechanism of negative regulation of gene expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8107237      PMCID: PMC236636     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Characterization of the hepatitis B virus EnhI enhancer and X promoter complex.

Authors:  W T Guo; K D Bell; J H Ou
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  The hepatitis B virus S promoter comprises A CCAAT motif and two initiation regions.

Authors:  D X Zhou; T S Yen
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

3.  Binding affinities and cooperative interactions with bHLH activators delimit threshold responses to the dorsal gradient morphogen.

Authors:  J Jiang; M Levine
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

4.  Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation.

Authors:  W Guo; M Chen; T S Yen; J H Ou
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

5.  Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus.

Authors:  C H Yuh; Y L Chang; L P Ting
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter.

Authors:  P Zhang; A K Raney; A McLachlan
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

7.  Modulation of liver-specific transcription by interactions between hepatocyte nuclear factor 3 and nuclear factor 1 binding DNA in close apposition.

Authors:  D A Jackson; K E Rowader; K Stevens; C Jiang; P Milos; K S Zaret
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

8.  The dorsal gradient morphogen regulates stripes of rhomboid expression in the presumptive neuroectoderm of the Drosophila embryo.

Authors:  Y T Ip; R E Park; D Kosman; E Bier; M Levine
Journal:  Genes Dev       Date:  1992-09       Impact factor: 11.361

9.  Differentiated liver cell specificity of the second enhancer of hepatitis B virus.

Authors:  C H Yuh; L P Ting
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

Review 10.  Negative regulation of eukaryotic transcription.

Authors:  M E Jackson
Journal:  J Cell Sci       Date:  1991-09       Impact factor: 5.285

View more
  12 in total

1.  Transcriptional repression of human hepatitis B virus genes by a bZIP family member, E4BP4.

Authors:  C K Lai; L P Ting
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated.

Authors:  X Yu; J E Mertz
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.

Authors:  H Ishida; K Ueda; K Ohkawa; Y Kanazawa; A Hosui; F Nakanishi; E Mita; A Kasahara; Y Sasaki; M Hori; N Hayashi
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.

Authors:  S Günther; N Piwon; A Iwanska; R Schilling; H Meisel; H Will
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 6.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

7.  Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1.

Authors:  Xianming Yu; Janet E Mertz
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Methylation regulates hepatitis B viral protein expression.

Authors:  Perumal Vivekanandan; David Thomas; Michael Torbenson
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

9.  The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity.

Authors:  Man-Shan Li; Terrence Chi-Kong Lau; Sophie Ka-Ping Chan; Chi-Hang Wong; Patrick Kwok-Shing Ng; Joseph Jao-Yiu Sung; Henry Lik-Yuen Chan; Stephen Kwok-Wing Tsui
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

10.  Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients.

Authors:  Masashi Tatsukawa; Akinobu Takaki; Hidenori Shiraha; Kazuko Koike; Yoshiaki Iwasaki; Haruhiko Kobashi; Shin-Ichi Fujioka; Kohsaku Sakaguchi; Kazuhide Yamamoto
Journal:  BMC Cancer       Date:  2011-10-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.